Julia Butt1,2, William J Blot3, Martha J Shrubsole4, Matthew G Varga5, Laura H Hendrix6, Sydnee Crankshaw1, Tim Waterboer2, Michael Pawlita2, Meira Epplein1. 1. Cancer Control and Population Sciences Program, Duke Cancer Institute and Department of Population Health Sciences, Duke University, Durham, NC, USA. 2. Infection and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. 3. Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Department of Epidemiology, University of North Carolina Gillings School for Global Public Health and the Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. 6. Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
Abstract
PURPOSE: To feasibly analyze associations of Helicobacter pylori (H. pylori) with disease in large cohort studies, assays are needed to assess H. pylori prevalence in existing biospecimens. However, serology has traditionally been unable to distinguish active from past infection. We sought to determine the sensitivity of seropositivity to H. pylori proteins to detect active infection. METHODS: We measured antibody responses to 13 H. pylori proteins using multiplex serology in serum samples of a training (n = 78) and validation set (n = 49) collected concurrently from patients undergoing urea breath test (UBT). To determine sensitivity of seropositivity to H. pylori proteins for active infection, a cutoff was applied to achieve 90% specificity. Antibody levels were retested in a subset of participants (n = 16) 6 months after baseline. RESULTS: With a specificity of 91%, seropositivity to H. pylori proteins VacA, GroEl, HcpC, and HP1564 ascertained active infection from 100% to 75% sensitivity. Positivity to a combination of these proteins (≥2 out of the 4) resulted in specificity of 90% and sensitivity of 100%. The validation set replicated results from the training set. Among those participants with successful H. pylori eradication after baseline, antibody levels decreased significantly for VacA, HcpC, and HP1564 when assessed 6 months later. CONCLUSION: Utilizing the cutoffs for seropositivity established through comparison with UBT, seropositivity to ≥2 of the H. pylori proteins VacA, GroEl, HcpC, and HP1564 determines active H. pylori infection at high specificity and sensitivity and may approximate the prevalence of active H. pylori infection in large cohorts.
PURPOSE: To feasibly analyze associations of Helicobacter pylori (H. pylori) with disease in large cohort studies, assays are needed to assess H. pylori prevalence in existing biospecimens. However, serology has traditionally been unable to distinguish active from past infection. We sought to determine the sensitivity of seropositivity to H. pylori proteins to detect active infection. METHODS: We measured antibody responses to 13 H. pylori proteins using multiplex serology in serum samples of a training (n = 78) and validation set (n = 49) collected concurrently from patients undergoing urea breath test (UBT). To determine sensitivity of seropositivity to H. pylori proteins for active infection, a cutoff was applied to achieve 90% specificity. Antibody levels were retested in a subset of participants (n = 16) 6 months after baseline. RESULTS: With a specificity of 91%, seropositivity to H. pylori proteins VacA, GroEl, HcpC, and HP1564 ascertained active infection from 100% to 75% sensitivity. Positivity to a combination of these proteins (≥2 out of the 4) resulted in specificity of 90% and sensitivity of 100%. The validation set replicated results from the training set. Among those participants with successful H. pylori eradication after baseline, antibody levels decreased significantly for VacA, HcpC, and HP1564 when assessed 6 months later. CONCLUSION: Utilizing the cutoffs for seropositivity established through comparison with UBT, seropositivity to ≥2 of the H. pylori proteins VacA, GroEl, HcpC, and HP1564 determines active H. pylori infection at high specificity and sensitivity and may approximate the prevalence of active H. pylori infection in large cohorts.
Authors: Lisa B Signorello; Margaret K Hargreaves; Mark D Steinwandel; Wei Zheng; Qiuyin Cai; David G Schlundt; Maciej S Buchowski; Carolyne W Arnold; Joseph K McLaughlin; William J Blot Journal: J Natl Med Assoc Date: 2005-07 Impact factor: 1.798
Authors: Lauren R Teras; Dana E Rollison; Michael Pawlita; Angelika Michel; Jennifer L Blase; Martina Willhauck-Fleckenstein; Susan M Gapstur Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-12-08 Impact factor: 4.254
Authors: Julia Butt; Matthew G Varga; William J Blot; Lauren Teras; Kala Visvanathan; Loïc Le Marchand; Christopher Haiman; Yu Chen; Ying Bao; Howard D Sesso; Sylvia Wassertheil-Smoller; Gloria Y F Ho; Lesley E Tinker; Richard M Peek; John D Potter; Timothy L Cover; Laura H Hendrix; Li-Ching Huang; Terry Hyslop; Caroline Um; Francine Grodstein; Mingyang Song; Anne Zeleniuch-Jacquotte; Sonja Berndt; Allan Hildesheim; Tim Waterboer; Michael Pawlita; Meira Epplein Journal: Gastroenterology Date: 2018-10-06 Impact factor: 22.682
Authors: Luca Formichella; Laura Romberg; Hannelore Meyer; Christian Bolz; Michael Vieth; Michael Geppert; Gereon Göttner; Christina Nölting; Wolfgang Schepp; Arne Schneider; Kurt Ulm; Petra Wolf; Ingrid Lisanne Holster; Ernst J Kuipers; Bernd Birkner; Erwin Soutschek; Markus Gerhard Journal: J Immunol Res Date: 2017-05-30 Impact factor: 4.818
Authors: María Fernanda González; Paula Díaz; Alejandra Sandoval-Bórquez; Daniela Herrera; Andrew F G Quest Journal: Int J Mol Sci Date: 2021-05-01 Impact factor: 5.923
Authors: Christian S Alvarez; Andrea A Florio; Julia Butt; Alvaro Rivera-Andrade; María F Kroker-Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D Freedman; Barry I Graubard; Mariana Lazo; Eliseo Guallar; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn Journal: Helicobacter Date: 2020-10-02 Impact factor: 5.182
Authors: Sydnee Crankshaw; Julia Butt; Jennifer M Gierisch; Nadine J Barrett; Sabrena Mervin-Blake; Kevin Oeffinger; Steven Patierno; Valarie Worthy; Ronald Godbee; Meira Epplein Journal: BMC Gastroenterol Date: 2020-08-06 Impact factor: 3.067
Authors: Meira Epplein; Loïc Le Marchand; Timothy L Cover; Mingyang Song; William J Blot; Richard M Peek; Lauren R Teras; Kala Visvanathan; Yu Chen; Howard D Sesso; Anne Zeleniuch-Jacquotte; Sonja I Berndt; John D Potter; Marc D Ryser; Christopher A Haiman; Sylvia Wassertheil-Smoller; Lesley F Tinker; Tim Waterboer; Julia Butt Journal: Microorganisms Date: 2020-10-30